Inovio Pharma (INO) Misses Q3 EPS by 89c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.12 +1.82%
EPS Growth %: +60.7%
Financial Fact:
Net loss: -20.76M
Today's EPS Names:
DTGI, OCCI, MAYS, More
EPS Growth %: +60.7%
Financial Fact:
Net loss: -20.76M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q3 EPS of ($0.89).
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Starts Hawkins (HWKN) at Equalweight
- UBS Downgrades EasyJet Plc. (EZJ:LN) (ESYJY) to Neutral
- Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
